Literature DB >> 24277331

A radioimmunoassay for determination of glibenclamide and other sulfonylureas.

W Heptner1, M Badian, S Baudner, C Hellstern, R Irmisch, W Rupp, K Weimer, H Wissmann.   

Abstract

An antiserum was prepared for the determination of glibenclamide and for the estimation of other commercially available sulfonylureas. Rabbits were immunized with a glibenclamide-BSA conjugate. Tritiated glibenclamide was used as the tracer. The assay was performed in the presence of 8-anilinonaphthalenesulfonic acid to displace glibenclamide bound to serum protein, and free and antibody bound tracer were separated by dextran-coated charcoal. For glibenclamide determination in serum and plasma the limit of detection was 3 ng/ml. Sensitivity calculated for the whole determination range was 102 cpm for a 10 % concentration difference. Specificity studies showed a cross-reaction of less than 0.1 % for glibenclamide metabolite M1 and 9 % for metabolite M2. Other sulfonylurea drugs display cross-reactivities from 0.1% (chlorpropamide) to 190% (gliquidone). Both intra-assay and inter-assay imprecision were below 10 %. Accuracy was established by comparison of the present method with HPLC. The assay was applied to the specific determination of glibenclamide in clinical trials and for diagnosing factitious hypoglycemia caused by sulfonylureas.

Entities:  

Year:  1984        PMID: 24277331     DOI: 10.1023/A:1016321313510

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  9 in total

1.  Gas chromatographic determination of glibenclamide in plasma.

Authors:  D Castoldi; O Tofanetti
Journal:  Clin Chim Acta       Date:  1979-04-16       Impact factor: 3.786

2.  Coupling of peptides to albumin with difluorodinitrobenzene.

Authors:  H S Tager
Journal:  Anal Biochem       Date:  1976-04       Impact factor: 3.365

3.  A radioimmunoassay for measurement of thyroxine in unextracted serum.

Authors:  I J Chopra
Journal:  J Clin Endocrinol Metab       Date:  1972-06       Impact factor: 5.958

4.  [Radioimmunologic determination of glibenclamide in serum].

Authors:  P Glogner; P Burmeister; N Heni
Journal:  Klin Wochenschr       Date:  1973-04-01

5.  [Resorption, excretion and metabolism after intravenous and oral administration of HB 419-14C in man].

Authors:  W Rupp; O Christ; W Heptner
Journal:  Arzneimittelforschung       Date:  1969-08

6.  [Physico-chemical and analytical studies on HB 419].

Authors:  P Hajdú; K F Kohler; F H Schmidt; H Spingler
Journal:  Arzneimittelforschung       Date:  1969-08

7.  High-performance liquid column and thin-layer chromatographic determination of human serum glibenclamide at therapeutic levels.

Authors:  M Uihlein; N Sistovaris
Journal:  J Chromatogr       Date:  1982-01-08

8.  Pharmacokinetics of intravenous glibenclamide investigated by a high performance liquid chromatographic assay.

Authors:  H J Rogers; R G Spector; P J Morrison; I D Bradbrook
Journal:  Diabetologia       Date:  1982-07       Impact factor: 10.122

9.  Radioimmunoassay of glibenclamide.

Authors:  K Kawashima; T Kuzuya; A Matsuda
Journal:  Diabetes       Date:  1979-03       Impact factor: 9.461

  9 in total
  2 in total

1.  Absorption of glibenclamide from different sites of the gastro-intestinal tract.

Authors:  D Brockmeier; H G Grigoleit; H Leonhardt
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

2.  Alterations of insulin secretion from mouse islets treated with sulphonylureas: perturbations of Ca2+ regulation prevail over changes in insulin content.

Authors:  M Anello; P Gilon; J C Henquin
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.